From determining the optimal commercial endpoints for a clinical trial to bolstering post launch product uptake in a decentralized autonomous region, HERON's market access experts are available for highly valued strategic direction, as well as results-driven execution.
While HERON market access services can be commissioned on a project basis, or within a particular discipline, we also offer subscribed services which give clients immediate access to a customized in-house team of experts who remain on point with your product/portfolio needs:
- Remaining astute to (global) issues, trends, and drivers that could impact commercial success
- Keeping your product team one step ahead in competitive positioning and differentiation
- Aligning all strategies, work streams, and evidence generation toward the achievement of pricing, reimbursement, and access for your product/portfolio
HERON’s Evidence-to-Access Decision Support™ Service is recommended for all products or portfolios, particularly those in most need of support, such as: highly competitive landscapes; robust portfolios looking to achieve and sustain market dominance, and/or where outcomes and other data that lend to product positioning could benefit from broader context/consideration (e.g. adding behavioral health or other patient engagement strategies to improve outcomes/comparative effectiveness).